A detailed history of Romano Brothers And Company transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Romano Brothers And Company holds 6,417 shares of EW stock, worth $584,460. This represents 0.08% of its overall portfolio holdings.

Number of Shares
6,417
Previous 6,537 1.84%
Holding current value
$584,460
Previous $498,000 23.09%
% of portfolio
0.08%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$72.54 - $95.56 $8,704 - $11,467
-120 Reduced 1.84%
6,417 $613,000
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $403,398 - $508,317
6,537 New
6,537 $498,000
Q3 2023

Oct 17, 2023

BUY
$69.28 - $93.38 $452,883 - $610,425
6,537 New
6,537 $452,000
Q3 2022

Oct 18, 2022

BUY
$82.37 - $107.29 $538,452 - $701,354
6,537 New
6,537 $540,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Romano Brothers And Company Portfolio

Follow Romano Brothers And Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Romano Brothers And Company, based on Form 13F filings with the SEC.

News

Stay updated on Romano Brothers And Company with notifications on news.